Abstract: A method of generating a report presenting subject-specific information relevant to a treatment of a neuropsychiatric disorder includes obtaining a set of genetic test results. The set of genetic test results includes allelic information for each gene in a set of genomic loci. The method includes obtaining a set of medications including a first medication and obtaining a first patient-specific evaluation associated with the first medication using the set of genetic test results. The method includes determining a set of alternative medications to the first medication and determining, for each respective alternative medication of the set of alternative medications, a corresponding alternative pharmacokinetic and pharmacodynamic patient-specific evaluation using the set of genetic test results.

Abstract: Systems and method for displaying a patient specific report are provided. The report includes a determination of an allele status for genomic loci. Each respective loci associates with an efficacy of a treatment for at least one neuropsychiatric disorder and one or more treatments of the at least one disorder. A respective graphical chart displays for each corresponding disorder including a respective first axis, a respective second axis, and respective data plots. The respective first axis segments into bins. Each respective bin associates with a respective independent first subset of loci and represents a respective treatment class. The second respective axis is associated with a characteristic of an efficacy of a treatment for the corresponding disorder. Each respective data plot represents a corresponding treatment, is within the corresponding bin, and independently located on the first respective axis based on an allele status for the respective independent first subset of loci.

Abstract: A novel safety timer for use with a baby bottle or the like comprises a timer portion and a band portion, where the band portion is reversibly retained on a baby bottle and holds the timer portion in a position suitable for use. The timer portion provides an indication of the status of the period of use during which the prepared formula is still considered to be safe to offer to the infant. The safety timer of the present invention may also include an identification tag to ensure the association of the baby bottle with a particular infant.